Calvin Sandra bought TVTX
January 31, 2026 · Form 4 insider transaction
Calvin Sandra bought 15,180 shares of Travere Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,180
Price
$0.00
Total value
N/A
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after53,413
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.